{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:27:19Z","timestamp":1790602039123,"version":"4.1.0"},"reference-count":41,"publisher":"Human Kinetics","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:p><jats:italic><jats:bold>Background<\/jats:bold>:<\/jats:italic> Nonalcoholic fatty liver disease (NAFLD) is a global health concern, and despite its high prevalence, lifestyle modifications such as exercise play a pivotal role in resolving this condition. This study aims to identify factors associated with NAFLD resolution, with a focus on the role of exercise, in different age groups. <jats:italic><jats:bold>Methods<\/jats:bold>:<\/jats:italic> Longitudinal data from Korean military officers, during the period 2019\u20132021, were obtained from the National Health Information Database. NAFLD was defined as a hepatic steatosis index \u226536, and NAFLD resolution was defined as individuals achieving hepatic steatosis index &lt;36 in the subsequent year of diagnosis. Information on alcohol consumption, exercise frequency, and family history of diabetes was collected through self-reported questionnaires. <jats:italic><jats:bold>Results<\/jats:bold>:<\/jats:italic> The analysis included a total of 163,728 individuals, with a mean age of\u00a036.87, predominantly male (91.62%). The prevalence of NAFLD was 27.04%. Favorable factors for NAFLD resolution encompassed moderate-intensity exercise for more than 180\u00a0minutes per week, vigorous-intensity exercise for more than 90\u00a0minutes per week, female sex, age, and resistance exercise for more than 3\u00a0days per week. Hypertension, family history of diabetes, and smoking were identified as factors against NAFLD resolution. The exercise requirements for NAFLD resolution varied among age groups, with those &lt;30\u00a0years old requiring more than 180\u00a0minutes per week of moderate- or vigorous-intensity exercise and those &gt;50\u00a0years old needing only 90\u00a0minutes per week of such exercise. <jats:italic><jats:bold>Conclusion<\/jats:bold>:<\/jats:italic> The exercise requirements for NAFLD resolution exhibit age-related differences. Individualized guidance for NAFLD management should consider these variations and be tailored to specific age groups.<\/jats:p>","DOI":"10.1123\/jpah.2024-0334","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:58:02Z","timestamp":1733950682000},"page":"323-333","source":"Crossref","is-referenced-by-count":1,"title":["Differential Exercise Requirements for Nonalcoholic Fatty Liver Disease Resolution Across Age Groups: A Longitudinal Study of Korean Military Officers"],"prefix":"10.1123","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4402-9350","authenticated-orcid":true,"given":"Jaejun","family":"Lee","sequence":"first","affiliation":[{"name":"The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Yeup","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-9495","authenticated-orcid":true,"given":"Jae Hyeop","family":"Jung","sequence":"additional","affiliation":[{"name":"Remote Reading Team, Armed Forces Capital Hospital, Seongnam, Gyeonggi-do, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunkyoung","family":"Bae","sequence":"additional","affiliation":[{"name":"Republic of Korea Army, Gyeryong, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-1194","authenticated-orcid":true,"given":"Jeong A.","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Korean Armed Forces Medical Command, Seongnam, Gyeonggi-do, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6588-9806","authenticated-orcid":true,"given":"Hyun","family":"Yang","sequence":"additional","affiliation":[{"name":"The Catholic University Liver Research Center, Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Eunpyeong St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"100","reference":[{"issue":"suppl","key":"r1","series-title":"Clin Mol Hepatol","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng ML","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, et\u00a0al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(suppl):S32\u2013S42. PubMed ID: 36517002 doi:10.3350\/cmh.2022.0365"},{"issue":"4","key":"r2","series-title":"Clin Res Hepatol Gastroenterol","doi-asserted-by":"publisher","first-page":"101526","DOI":"10.1016\/j.clinre.2020.06.022","article-title":"Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea","volume":"45","author":"Im HJ","year":"2021","unstructured":"Im HJ, Ahn YC, Wang JH, Lee MM, Son CG. Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clin Res Hepatol Gastroenterol. 2021;45(4):101526. PubMed ID: 32919911 doi:10.1016\/j.clinre.2020.06.022"},{"issue":"2","key":"r3","series-title":"Clin Mol Hepatol","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3350\/cmh.2021.0371","article-title":"Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: a Korean military population-based cross-sectional study","volume":"28","author":"Lee J","year":"2022","unstructured":"Lee J, Kim T, Yang H, Bae SH. Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: a Korean military population-based cross-sectional study. Clin Mol Hepatol. 2022;28(2):196\u2013206. PubMed ID: 35021598 doi:10.3350\/cmh.2021.0371"},{"issue":"6","key":"r4","series-title":"J Clin Gastroenterol","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/mcg.0000000000001739","article-title":"Global burden of nonalcoholic fatty liver disease, 1990 to 2019: findings from the Global Burden of Disease Study 2019","volume":"57","author":"Jiang W","year":"2023","unstructured":"Jiang W, Mao X, Liu Z, Zhang T, Jin L, Chen X. Global burden of nonalcoholic fatty liver disease, 1990 to 2019: findings from the Global Burden of Disease Study 2019. J Clin Gastroenterol. 2023;57(6):631\u2013639. PubMed ID: 35921320 doi:10.1097\/mcg.0000000000001739"},{"issue":"11","key":"r5","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison SA","year":"2023","unstructured":"Harrison SA, Taub R, Neff GW, et\u00a0al. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2023;29(11):2919\u20132928. PubMed ID: 37845512 doi:10.1038\/s41591-023-02603-1"},{"issue":"3","key":"r6","series-title":"Gastroenterology","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review","volume":"160","author":"Younossi ZM","year":"2021","unstructured":"Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review. Gastroenterology. 2021;160(3):912\u2013918. PubMed ID: 33307021 doi:10.1053\/j.gastro.2020.11.051"},{"issue":"3","key":"r7","series-title":"Clin Mol Hepatol","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3350\/cmh.2021.0178","article-title":"KASL clinical practice guidelines: management of nonalcoholic fatty liver disease","volume":"27","author":"Kang SH","year":"2021","unstructured":"Kang SH, Lee HW, Yoo JJ, et\u00a0al. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2021;27(3):363\u2013401. PubMed ID: 34154309 doi:10.3350\/cmh.2021.0178"},{"issue":"11","key":"r8","series-title":"Nutrients","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113472","article-title":"Physiopathology of lifestyle interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"12","author":"Carneros D","year":"2020","unstructured":"Carneros D, L\u00f3pez-Lluch G, Bustos M. Physiopathology of lifestyle interventions in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients. 2020;12(11). PubMed ID: 33198247 doi:10.3390\/nu12113472"},{"issue":"10","key":"r9","series-title":"Obes Rev","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/obr.12719","article-title":"The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis","volume":"19","author":"Sargeant JA","year":"2018","unstructured":"Sargeant JA, Gray LJ, Bodicoat DH, et\u00a0al. The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis. Obes Rev. 2018;19(10):1446\u20131459. PubMed ID: 30092609 doi:10.1111\/obr.12719"},{"issue":"9","key":"r10","series-title":"Dig Liver Dis","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.dld.2022.12.013","article-title":"Effect of exercise-based interventions in nonalcoholic fatty liver disease: a systematic review with meta-analysis","volume":"55","author":"Nam H","year":"2023","unstructured":"Nam H, Yoo JJ, Cho Y, et\u00a0al. Effect of exercise-based interventions in nonalcoholic fatty liver disease: a systematic review with meta-analysis. Dig Liver Dis. 2023;55(9):1178\u20131186. PubMed ID: 36653265 doi:10.1016\/j.dld.2022.12.013"},{"issue":"2","key":"r11","series-title":"J Clin Transl Hepatol","doi-asserted-by":"publisher","first-page":"120","DOI":"10.14218\/jcth.2019.00012","article-title":"Effect of exercise on NAFLD and its risk factors: comparison of moderate versus low intensity exercise","volume":"8","author":"Nath P","year":"2020","unstructured":"Nath P, Panigrahi MK, Sahu MK, et\u00a0al. Effect of exercise on NAFLD and its risk factors: comparison of moderate versus low intensity exercise. J Clin Transl Hepatol. 2020;8(2):120\u2013126. PubMed ID: 32832391 doi:10.14218\/jcth.2019.00012"},{"issue":"1","key":"r12","series-title":"J Hepatol","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2015.02.022","article-title":"Effect of aerobic exercise training dose on liver fat and visceral adiposity","volume":"63","author":"Keating SE","year":"2015","unstructured":"Keating SE, Hackett DA, Parker HM, et\u00a0al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol. 2015;63(1):174\u2013182. PubMed ID: 25863524 doi:10.1016\/j.jhep.2015.02.022"},{"issue":"suppl","key":"r13","series-title":"Clin Mol Hepatol","doi-asserted-by":"publisher","first-page":"S319","DOI":"10.3350\/cmh.2022.0366","article-title":"The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: a systematic review","volume":"29","author":"Chen G","year":"2023","unstructured":"Chen G, Banini B, Do A, Lim JK. The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: a systematic review. Clin Mol Hepatol. 2023;29(suppl):S319\u2013S332. PubMed ID: 36517000 doi:10.3350\/cmh.2022.0366"},{"issue":"5","key":"r14","series-title":"JHEP Rep","doi-asserted-by":"publisher","first-page":"100322","DOI":"10.1016\/j.jhepr.2021.100322","article-title":"Non-alcoholic fatty liver disease: a patient guideline","volume":"3","author":"Francque SM","year":"2021","unstructured":"Francque SM, Marchesini G, Kautz A, et\u00a0al. Non-alcoholic fatty liver disease: a patient guideline. JHEP Rep. 2021;3(5):100322. PubMed ID: 34693236 doi:10.1016\/j.jhepr.2021.100322"},{"issue":"9","key":"r15","series-title":"Med Sci Sports Exerc","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1249\/mss.0000000000003199","article-title":"Physical activity and nonalcoholic fatty liver disease: a roundtable statement from the American College of Sports Medicine","volume":"55","author":"Stine JG","year":"2023","unstructured":"Stine JG, Long MT, Corey KE, et\u00a0al. Physical activity and nonalcoholic fatty liver disease: a roundtable statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2023;55(9):1717\u20131726. PubMed ID: 37126039 doi:10.1249\/mss.0000000000003199"},{"issue":"5","key":"r16","series-title":"Hepatology","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/hep.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et\u00a0al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u20131835. PubMed ID: 36727674 doi:10.1097\/hep.0000000000000323"},{"issue":"1","key":"r17","series-title":"Diabetol Metab Syndr","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","article-title":"Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes","volume":"14","author":"Lin Y","year":"2022","unstructured":"Lin Y, Feng X, Cao X, et\u00a0al. Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes. Diabetol Metab Syndr. 2022;14(1):181. PubMed ID: 36443867 doi:10.1186\/s13098-022-00930-w"},{"issue":"7","key":"r18","series-title":"Dig Liver Dis","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee JH","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et\u00a0al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u2013508. PubMed ID: 19766548 doi:10.1016\/j.dld.2009.08.002"},{"issue":"9","key":"r19","series-title":"J Clin Med","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092851","article-title":"Comparative assessment and external validation of hepatic steatosis formulae in a community-based setting","volume":"9","author":"Jung TY","year":"2020","unstructured":"Jung TY, Kim MS, Hong HP, Kang KA, Jun DW. Comparative assessment and external validation of hepatic steatosis formulae in a community-based setting. J Clin Med. 2020;9(9). PubMed ID: 32899243 doi:10.3390\/jcm9092851"},{"issue":"1","key":"r20","series-title":"Eur J Med Res","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s40001-023-01536-2","article-title":"Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang","volume":"28","author":"Guo Y","year":"2023","unstructured":"Guo Y, Hu Y, Yang J, et\u00a0al. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang. Eur J Med Res. 2023;28(1):555. PubMed ID: 38042816 doi:10.1186\/s40001-023-01536-2"},{"issue":"6","key":"r21","series-title":"J Hepatol","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et\u00a0al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u20131556. PubMed ID: 37364790 doi:10.1016\/j.jhep.2023.06.003"},{"issue":"2","key":"r22","series-title":"J Obes Metab Syndr","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7570\/jomes22024","article-title":"Obesity Fact Sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019","volume":"31","author":"Yang YS","year":"2022","unstructured":"Yang YS, Han BD, Han K, Jung JH, Son JW. Obesity Fact Sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr. 2022;31(2):169\u2013177. PubMed ID: 35770450 doi:10.7570\/jomes22024"},{"issue":"7","key":"r23","series-title":"J Korean Acad Fam Med","first-page":"532","article-title":"Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) short form","volume":"28","author":"Oh JY","year":"2007","unstructured":"Oh JY, Yang YJ, Kim BS, Kang JH. Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) short form. J Korean Acad Fam Med. 2007;28(7):532\u2013541. http:\/\/www.kjfm.or.kr\/journal\/view.php?number=318"},{"issue":"3","key":"r24","series-title":"Korean J Fam Med","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4082\/kjfm.2012.33.3.144","article-title":"Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly","volume":"33","author":"Chun MY","year":"2012","unstructured":"Chun MY. Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly. Korean J Fam Med. 2012;33(3):144\u2013151. PubMed ID: 22787536 doi:10.4082\/kjfm.2012.33.3.144"},{"issue":"8","key":"r25","series-title":"Med Sci Sports Exerc","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"2011 Compendium of physical activities: a second update of codes and MET values","volume":"43","author":"Ainsworth BE","year":"2011","unstructured":"Ainsworth BE, Haskell WL, Herrmann SD, et\u00a0al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575\u20131581. PubMed ID: 21681120 doi:10.1249\/MSS.0b013e31821ece12"},{"issue":"1","key":"r26","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"15952","DOI":"10.1038\/s41598-017-16159-x","article-title":"Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: a randomized controlled trial","volume":"7","author":"Cheng S","year":"2017","unstructured":"Cheng S, Ge J, Zhao C, et\u00a0al. Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: a randomized controlled trial. Sci Rep. 2017;7(1):15952. PubMed ID: 29162875 doi:10.1038\/s41598-017-16159-x"},{"issue":"4","key":"r27","series-title":"Hepatology","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/hep.26393","article-title":"Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial)","volume":"58","author":"Bacchi E","year":"2013","unstructured":"Bacchi E, Negri C, Targher G, et\u00a0al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology. 2013;58(4):1287\u20131295. PubMed ID: 23504926 doi:10.1002\/hep.26393"},{"issue":"1","key":"r28","series-title":"Clin Hypertens","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40885-023-00234-9","article-title":"The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension","volume":"29","author":"Kim HL","year":"2023","unstructured":"Kim HL, Lee EM, Ahn SY, et\u00a0al. The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension. Clin Hypertens. 2023;29(1):11. PubMed ID: 36788612 doi:10.1186\/s40885-023-00234-9"},{"key":"r29","series-title":"Front Med","doi-asserted-by":"publisher","first-page":"578001","DOI":"10.3389\/fmed.2020.578001","article-title":"Hypoxia and non-alcoholic fatty liver disease","volume":"7","author":"Isaza SC","year":"2020","unstructured":"Isaza SC, Del Pozo-Maroto E, Dom\u00ednguez-Alc\u00f3n L, Elbouayadi L, Gonz\u00e1lez-Rodr\u00edguez \u00c1, Garc\u00eda-Monz\u00f3n C. Hypoxia and non-alcoholic fatty liver disease. Front Med. 2020;7:578001. PubMed ID: 33195326 doi:10.3389\/fmed.2020.578001"},{"issue":"10","key":"r30","series-title":"Antioxid Redox Signal","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1089\/ars.2011.4498","article-title":"Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling","volume":"18","author":"Radak Z","year":"2013","unstructured":"Radak Z, Zhao Z, Koltai E, Ohno H, Atalay M. Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid Redox Signal. 2013;18(10):1208\u20131246. PubMed ID: 22978553 doi:10.1089\/ars.2011.4498"},{"issue":"1","key":"r31","series-title":"J Pers Med","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/jpm11010006","article-title":"Impact of genetic factors on the age of onset for type 2 diabetes mellitus in addition to the conventional risk factors","volume":"11","author":"Piko P","year":"2020","unstructured":"Piko P, Werissa NA, Fiatal S, Sandor J, Adany R. Impact of genetic factors on the age of onset for type 2 diabetes mellitus in addition to the conventional risk factors. J Pers Med. 2020;11(1):6. PubMed ID: 33375163 doi:10.3390\/jpm11010006"},{"issue":"4","key":"r32","series-title":"Endocrinol Metab","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3803\/EnM.2022.1501","article-title":"Characteristics of glycemic control and long-term complications in patients with young-onset type 2 diabetes","volume":"37","author":"Baek HS","year":"2022","unstructured":"Baek HS, Park JY, Yu J, et\u00a0al. Characteristics of glycemic control and long-term complications in patients with young-onset type 2 diabetes. Endocrinol Metab. 2022;37(4):641\u2013651. PubMed ID: 36065646 doi:10.3803\/EnM.2022.1501"},{"issue":"1","key":"r33","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"24084","DOI":"10.1038\/s41598-021-03583-3","article-title":"A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight","volume":"11","author":"De Pergola G","year":"2021","unstructured":"De Pergola G, Castellana F, Zupo R, et\u00a0al. A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight. Sci Rep. 2021;11(1):24084. PubMed ID: 34916558 doi:10.1038\/s41598-021-03583-3"},{"issue":"1","key":"r34","series-title":"J Diabetes Complications","doi-asserted-by":"publisher","first-page":"108083","DOI":"10.1016\/j.jdiacomp.2021.108083","article-title":"First-degree family history of diabetes is associated with nonalcoholic fatty liver disease independent of glucose metabolic status","volume":"36","author":"Hu X","year":"2022","unstructured":"Hu X, Yu W, Yang L, et\u00a0al. First-degree family history of diabetes is associated with nonalcoholic fatty liver disease independent of glucose metabolic status. J Diabetes Complications. 2022;36(1):108083. PubMed ID: 34840086 doi:10.1016\/j.jdiacomp.2021.108083"},{"key":"r35","series-title":"SAGE Open Med","doi-asserted-by":"publisher","first-page":"2050312117745223","DOI":"10.1177\/2050312117745223","article-title":"Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"6","author":"Akhavan Rezayat A","year":"2018","unstructured":"Akhavan Rezayat A, Dadgar Moghadam M, Ghasemi Nour M, et\u00a0al. Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis. SAGE Open Med. 2018;6:2050312117745223. PubMed ID: 29399359 doi:10.1177\/2050312117745223"},{"issue":"2","key":"r36","series-title":"J Liver Cancer","doi-asserted-by":"publisher","first-page":"253","DOI":"10.17998\/jlc.2024.06.02","article-title":"Heavy Smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment","volume":"24","author":"Lee J","year":"2024","unstructured":"Lee J, Choi JY, Lee SK. Heavy Smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment. J Liver Cancer. 2024;24(2):253\u2013262. PubMed ID: 38852989 doi:10.17998\/jlc.2024.06.02"},{"issue":"1","key":"r37","series-title":"BMC Gastroenterol","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12876-020-01204-3","article-title":"Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials","volume":"20","author":"Wang ST","year":"2020","unstructured":"Wang ST, Zheng J, Peng HW, et\u00a0al. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2020;20(1):66. PubMed ID: 32164541 doi:10.1186\/s12876-020-01204-3"},{"issue":"10","key":"r38","series-title":"JAMA Netw Open","doi-asserted-by":"publisher","first-page":"e2338952","DOI":"10.1001\/jamanetworkopen.2023.38952","article-title":"Young adult physical activity trajectories and midlife nonalcoholic fatty liver disease","volume":"6","author":"de Brito JN","year":"2023","unstructured":"de Brito JN, McDonough DJ, Mathew M, et\u00a0al. Young adult physical activity trajectories and midlife nonalcoholic fatty liver disease. JAMA Netw Open. 2023;6(10):e2338952. PubMed ID: 37862012 doi:10.1001\/jamanetworkopen.2023.38952"},{"issue":"5","key":"r39","series-title":"Lancet Gastroenterol Hepatol","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/s2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"Li J","year":"2019","unstructured":"Li J, Zou B, Yeo YH, et\u00a0al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389\u2013398. PubMed ID: 30902670 doi:10.1016\/s2468-1253(19)30039-1"},{"issue":"7","key":"r40","series-title":"J Gastroenterol Hepatol","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/jgh.12935","article-title":"Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone","volume":"30","author":"Seo NK","year":"2015","unstructured":"Seo NK, Koo HS, Haam JH, et\u00a0al. Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone. J Gastroenterol Hepatol. 2015;30(7):1211\u20131216. PubMed ID: 25708291 doi:10.1111\/jgh.12935"},{"issue":"4","key":"r41","series-title":"Dig Liver Dis","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.dld.2017.12.014","article-title":"Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease","volume":"50","author":"Kim D","year":"2018","unstructured":"Kim D, Chung GE, Kwak MS, Kim YJ, Yoon JH. Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease. Dig Liver Dis. 2018;50(4):389\u2013395. PubMed ID: 29373238 doi:10.1016\/j.dld.2017.12.014"}],"container-title":["Journal of Physical Activity and Health"],"original-title":[],"link":[{"URL":"https:\/\/journals.humankinetics.com\/view\/journals\/jpah\/22\/3\/article-p323.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.humankinetics.com\/downloadpdf\/journals\/jpah\/22\/3\/article-p323.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.humankinetics.com\/downloadpdf\/journals\/jpah\/22\/3\/article-p323.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T17:19:48Z","timestamp":1740590388000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.humankinetics.com\/view\/journals\/jpah\/22\/3\/article-p323.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":41,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1123\/jpah.2024-0334","relation":{},"ISSN":["1543-3080","1543-5474"],"issn-type":[{"value":"1543-3080","type":"print"},{"value":"1543-5474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}